BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 26527248)

  • 1. A case control study of association between cognition and functional capacity in schizophrenia.
    Narayanan SS; Bhatia T; Velligan DI; Nimgaonkar VL; Deshpande SN
    Schizophr Res; 2015 Dec; 169(1-3):165-168. PubMed ID: 26527248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the CogState Schizophrenia Battery and the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Battery in assessing cognitive impairment in chronic schizophrenia.
    Pietrzak RH; Olver J; Norman T; Piskulic D; Maruff P; Snyder PJ
    J Clin Exp Neuropsychol; 2009 Oct; 31(7):848-59. PubMed ID: 19142774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive and clinical predictors of functional capacity in patients with first episode schizophrenia.
    Vesterager L; Christensen TØ; Olsen BB; Krarup G; Melau M; Forchhammer HB; Nordentoft M
    Schizophr Res; 2012 Nov; 141(2-3):251-6. PubMed ID: 23017825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virtual reality assessment of functional capacity in the early course of schizophrenia: Associations with cognitive performance and daily functioning.
    Ventura J; Welikson T; Ered A; Subotnik KL; Keefe RSE; Hellemann GS; Nuechterlein KH
    Early Interv Psychiatry; 2020 Feb; 14(1):106-114. PubMed ID: 31183960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An optimal combination of MCCB and CANTAB to assess functional capacity in older individuals with schizophrenia.
    Kumar S; Mulsant BH; Tsoutsoulas C; Ghazala Z; Voineskos AN; Bowie CR; Rajji TK
    Int J Geriatr Psychiatry; 2016 Oct; 31(10):1116-23. PubMed ID: 27428251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of the Brief UCSD Performance-based Skills Assessment (UPSA-B) to multiple indicators of functioning in people with schizophrenia and bipolar disorder.
    Mausbach BT; Harvey PD; Pulver AE; Depp CA; Wolyniec PS; Thornquist MH; Luke JR; McGrath JA; Bowie CR; Patterson TL
    Bipolar Disord; 2010 Feb; 12(1):45-55. PubMed ID: 20148866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 10-minute measure of global cognition: Validation of the Brief Cognitive Assessment Tool for Schizophrenia (B-CATS).
    Hurford IM; Ventura J; Marder SR; Reise SP; Bilder RM
    Schizophr Res; 2018 May; 195():327-333. PubMed ID: 28918221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophrenia.
    Buchanan RW; Keefe RS; Lieberman JA; Barch DM; Csernansky JG; Goff DC; Gold JM; Green MF; Jarskog LF; Javitt DC; Kimhy D; Kraus MS; McEvoy JP; Mesholam-Gately RI; Seidman LJ; Ball MP; McMahon RP; Kern RS; Robinson J; Marder SR
    Biol Psychiatry; 2011 Mar; 69(5):442-9. PubMed ID: 21145041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor structure of the MATRICS Consensus Cognitive Battery (MCCB) in schizophrenia.
    Burton CZ; Vella L; Harvey PD; Patterson TL; Heaton RK; Twamley EW
    Schizophr Res; 2013 May; 146(1-3):244-8. PubMed ID: 23507359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystallized verbal skills in schizophrenia: relationship to neurocognition, symptoms, and functional status.
    Kurtz MM; Donato J; Rose J
    Neuropsychology; 2011 Nov; 25(6):784-791. PubMed ID: 21928906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring Cognition in Bipolar Disorder with Psychosis Using the MATRICS Consensus Cognitive Battery.
    Sperry SH; O'Connor LK; Öngür D; Cohen BM; Keshavan MS; Lewandowski KE
    J Int Neuropsychol Soc; 2015 Jul; 21(6):468-72. PubMed ID: 26154947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor structure of cognitive performance and functional capacity in schizophrenia: Evidence for differences across functional capacity measures.
    Harvey PD; Horan WP; Atkins AS; Stevens H; Welch M; Yuan J; Patterson TL; Narasimhan M; Keefe RSE
    Schizophr Res; 2020 Sep; 223():297-304. PubMed ID: 32928621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Schizophrenia Cognition Rating Scale: an interview-based assessment and its relationship to cognition, real-world functioning, and functional capacity.
    Keefe RS; Poe M; Walker TM; Kang JW; Harvey PD
    Am J Psychiatry; 2006 Mar; 163(3):426-32. PubMed ID: 16513863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional significance of preserved affect recognition in schizophrenia.
    Fiszdon JM; Johannesen JK
    Psychiatry Res; 2010 Apr; 176(2-3):120-5. PubMed ID: 20202689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia.
    Javitt DC; Buchanan RW; Keefe RS; Kern R; McMahon RP; Green MF; Lieberman J; Goff DC; Csernansky JG; McEvoy JP; Jarskog F; Seidman LJ; Gold JM; Kimhy D; Nolan KS; Barch DS; Ball MP; Robinson J; Marder SR
    Schizophr Res; 2012 Apr; 136(1-3):25-31. PubMed ID: 22169248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of the MATRICS Consensus Cognitive Battery in a 29-site antipsychotic schizophrenia clinical trial.
    Keefe RS; Fox KH; Harvey PD; Cucchiaro J; Siu C; Loebel A
    Schizophr Res; 2011 Feb; 125(2-3):161-8. PubMed ID: 21075600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlations of functional capacity and neuropsychological performance in older patients with schizophrenia: evidence for specificity of relationships?
    McClure MM; Bowie CR; Patterson TL; Heaton RK; Weaver C; Anderson H; Harvey PD
    Schizophr Res; 2007 Jan; 89(1-3):330-8. PubMed ID: 16982175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between working memory capacity and broad measures of cognitive ability in healthy adults and people with schizophrenia.
    Johnson MK; McMahon RP; Robinson BM; Harvey AN; Hahn B; Leonard CJ; Luck SJ; Gold JM
    Neuropsychology; 2013 Mar; 27(2):220-9. PubMed ID: 23527650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An ecologically valid performance-based social functioning assessment battery for schizophrenia.
    Shi C; He Y; Cheung EF; Yu X; Chan RC
    Psychiatry Res; 2013 Dec; 210(3):787-93. PubMed ID: 24126188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.